CD44 and breast carcinoma: While the exact origin of cancer stem cells (CSCs) remains elusive, biomarkers for breast cancer stem cells (BCSCs) have been identified, such as CD44+ve/CD24−ve/low cells that exhibit aggressive behavior and drug resistance [45].